Delivery Order HHSN272201100021I-HHSN27200024
Award Date 9/26/14
Potential Completion Date 6/30/25
Potential Value $7.9M
Federal Agency
Ultimate Awardee
Not listed NAICS Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Cost Plus Fixed Fee
Place of Performance
Potomac, MD 20850, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a $3,017,609 cost-plus-fixed-fee delivery order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Advanced Bioscience Laboratories, Inc. (ABL) for fill-finish, release, and stability testing of HIV-1 gp120 proteins. The contract has an ultimate completion date of April 15, 2025. ABL is a for-profit organization that specializes in the development of biologics, vaccines, and immunotherapies....
- This is a $6,095,159.00 cost-plus-fixed-fee delivery order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to Advanced Bioscience Laboratories, Inc. (ABL) for expertise in professional pharmaceutical project management. The contract is issued under the larger Resources to Advance Pediatrics and HIV Prevention Science indefinite-delivery/indefinite-quantity (IDIQ) contract vehicle. ABL, a manufacturer of biologics including vaccines and monoclonal antibodies,...
- This is a $2,696,523.00 delivery order awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to Advanced Bioscience Laboratories, Inc. (ABL), a for-profit manufacturer, for NIAID's Preclinical Development Support program. The contract has a period of performance through December 31, 2026 and is a cost-plus-fixed-fee type. ABL, a leading contract research and manufacturing organization, provides a range of preclinical and clinical development services to support...
- This is a federal contract award from the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. Department of Health and Human Services, to Advanced Bioscience Laboratories, Inc. (ABL), a for-profit manufacturer of goods. The contract is for the production of HIV-1gp120 protein in support of NIAID's preclinical development program. The contract, which does not have a set-aside designation, has a ceiling value of $4,240,924.91 and an ultimate...
- This is a cost-plus-fixed-fee delivery order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the Department of Health and Human Services (HHS), to Advanced Bioscience Laboratories, Inc. (ABL) for R&D and medical support services related to AIDS research. The contract has a ceiling value of $2,857,610.47 and a period of performance through August 29, 2024. This award is not associated with a set-aside program. ABL, a foreign-owned, for-profit...
- This is a federal contract award from the National Institute of Allergy and Infectious Diseases (NIAID), a component of the U.S. Department of Health and Human Services (HHS), to Advanced Bioscience Laboratories, Inc. (ABL) for the production of an ECD-Ig protein as part of the NIAID Preclinical Development Support program. The contract has a ceiling value of $10,181,787.99 and a period of performance ending on January 31, 2024. The contract is a Delivery Order with a Cost Plus Fixed Fee pricing...
- This federal contract award was made by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. Department of Health and Human Services, to Advanced Bioscience Laboratories, Inc. (ABL). The $9,967,500.00 cost-plus-fixed-fee contract supports NIAID's Preclinical Development program, specifically the production of the MHRP GP145 Clade C trimer protein. This contract does not have a set-aside designation. ABL, a for-profit manufacturer of goods, has been...
- This is a cost-plus-fixed-fee delivery order contract awarded by the Department of Health and Human Services' National Institutes of Health National Institute of Allergy and Infectious Diseases (NIAID) to Advanced Bioscience Laboratories, Inc. (ABL), a foreign-owned for-profit manufacturer of goods. The $8,997,298.00 contract supports the production of ALVAC-HIV drug product and diluent as part of NIAID's Preclinical Development Support program. ABL, a contract research and manufacturing...
- This is a definitive, cost-plus-fixed-fee contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to Advanced Bioscience Laboratories, Inc. (ABL), a foreign-owned, for-profit manufacturer of goods. The contract, valued at $213,045,738.00, is for preclinical development services to support infectious disease research and product development initiatives. The contract does not have a set-aside designation. ABL has been awarded numerous federal contracts and grants,...
- This is a cost-plus-fixed-fee delivery order contract awarded by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) to Advanced Bioscience Laboratories, Inc. (ABL), a foreign-owned for-profit manufacturer. The $2,152,834.00 contract is for preclinical development support services, including biologics manufacturing, testing, storage, shipping, and quality assurance. ABL has been awarded over $35...